| Financial Year |
March 31 2023 |
| Monetary Funds |
159,873,741.16 |
| Held-for-trading Financial Assets |
145,212.56 |
| Notes Receivable |
200,000.00 |
| Accounts Receivable |
359,865,571.47 |
| Advances to Suppliers |
5,181,118.96 |
| Other Receivables |
3,939,326.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
85,146,854.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,742,106.01 |
| Total Current Assets |
637,304,461.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
850,724.48 |
| Investment Properties |
-- |
| Fixed Assetes |
501,678,631.93 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,247,374.61 |
| R&D expenses |
-- |
| Goodwill |
83,011,486.65 |
| Long-Term Deferred and Prepaid Expenses |
1,454,938.02 |
| Deferred Income Tax Assets |
10,100,371.35 |
| Other Non-Current Assets |
1,898,954.83 |
| Sub-Total of Non-Current Assets |
619,743,463.67 |
| Total Assets |
1,257,047,925.59 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
51,290,430.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,330,125.32 |
| Taxes Payable |
13,736,609.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,281,505.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,678,354.71 |
| Other Current Liabilities |
17,009.40 |
| Sub-Total of Current Liabilities |
117,200,398.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,185,681.67 |
| Other Non-Current Liabilities |
3,603,791.73 |
| Sub-Total of Non-Current Liabilities |
13,452,858.06 |
| Total Liabilities |
130,653,256.60 |
| Paid-In Capital(Or Share Stock) |
137,829,078.00 |
| Capital Surplus |
574,605,246.50 |
| Surplus Reserve |
61,949,929.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
352,010,414.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,126,394,668.99 |
| Owner's Equity（Stockholder's Equity） |
1,126,394,668.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,257,047,925.59 |
